Medical trials are currently being conducted at Alivation—this is your chance to help science and medicine. Study-related exams, tests and medication will be provided at no cost, and you may be compensated for your time.

Review the open research studies below and apply for the one(s) you qualify for by filling out Join a Study Form. Check out our list of studies or contact us with any questions. Participation in all research is voluntary and not everyone may qualify. If you are interested in learning how you can assist in scientific research, or if you’d like to participate in a study for a condition not listed, please call 402.476.6060, option 4.

If you would like to submit research study ideas, or if you have any questions about studies, please send an email to research@alivation.com. 

Current Pharmaceutical Research Trials:
  • Phase 2 study evaluating an investigational medication as an adjunct therapy for patients diagnosed with Major Depressive Disorder or who have been experiencing symptoms of depression for at least 12 weeks.
  • Duration of the study is 6-8 weeks, consisting of 8 visits to the clinic
  • Must be currently experiencing moderate to severe symptoms of depression
  • Must have had an unsatisfactory response to at least 2 antidepressants during the current depressive episode
  • Compensation for your time and travel is offered
  • Phase 3 study evaluating an investigational medication as an adjunct therapy for patients diagnosed with Major Depressive Disorder and experience insomnia or trouble sleeping
  • The duration of the study is 13 weeks, consisting of 13 visits to the clinic
  • Must be currently experiencing moderate to severe symptoms of depression
  • Must have had an unsatisfactory response to at least 1 antidepressant, but no more than 2 antidepressants, during the current depressive episode
  • Compensation for your time and travel is offered
  • Phase 3 study evaluating an investigational medication plus Sertraline for patients diagnosed with Major Depressive Disorder or who have been experiencing symptoms of depression for at least 4 weeks.
  • The duration of the study is 8 weeks, consisting of 11 visits to the clinic
  • Must be currently experiencing moderate to severe symptoms of depression
  • Must be willing to delay the start of any medication for depression (other than the study medication and an antidepressant)
  • Compensation for your time and travel is offered
  • Phase 3 study evaluating an investigational medication for pediatric patients with Generalized Anxiety Disorder or experiencing symptoms of anxiety
  • The duration of the study is 10 weeks, consisting of 8 visits to the clinic
  • Must be currently experiencing moderate to severe symptoms of anxiety including excessive worrying and dread or fearful anticipation
  • Must not be currently on any psychiatric medication
  • Compensation for your time and travel is offered
  • Study evaluating an investigational medication for pediatric patients with Tourette’s syndrome or experiencing vocal and motor tics
  • The duration of the study is 20 weeks, consisting of 11 visits to the clinic
  • Must be currently experiencing either vocal or motor tics and has to have experienced at least one of both in the past
  • Tics must be causing either discomfort, social or emotional problems, or interference in one’s life
  • Compensation for your time and travel is offered
  • Study evaluating the safety and effectiveness of VNS as an adjunctive therapy for adults with treatment-resistant depression
  • The duration of the study is 64 months, consisting of 25 visits to the clinic
  • Must be currently diagnosed with Major Depressive Disorder or Bipolar Disorder and currently in a depressed mood
  • Must have tried and failed 4 treatments for depression
  • Compensation for your time and travel is offered
  • Phase 4 study evaluating an investigational medication for pediatric patients with ADHD
  • The duration of the study is 56 weeks, consisting of 17 visits to the clinic
  • Must be currently experiencing moderate to severe symptoms of ADHD
  • Compensation for your time and travel is offered
  • Must be currently experiencing 1 to 6 moderate to severe migraine attacks per month
  • Compensation for your time and travel is offered
  • Phase 2 study evaluating a medication in obese adult patients with Schizophrenia taking an antipsychotic medication
  • The duration of the study is 30 weeks, consisting of 11 visits to the site
  • Must have a diagnosis of Schizophrenia and is currently taking an antipsychotic which has caused weight gain
  • Compensation for your time and travel is offered
Current TMS Research Trails:

Check back here to see new TMS studies.

Upcoming Studies

More details on this study are coming soon.

Our dedicated research staff is certified to conduct clinical trials according to Good Clinical Practices (GCP), adhering to all written standard operating procedures (SOPs) and HIPPA regulations.